Review this article to help us continue creating and sharing relevant content.
The House of Representatives in Cyprus have passed a law regulating the production, use and import of medicinal cannabis.
A Senate subcommittee approved a bill early this week that would allow patients to access medical cannabis for a wider range of health problems than previously depicted.
The addition of two new conditions that qualify for medical marijuana in Minnesota have gone into effect as of July 1st, after being approved by the Minnesota Department of Health in November.
A bill to legalize cannabis-based medicines that was approved last month by the Portuguese Parliament officially went into law July 1.
On November 2 Utah voters will see Proposition 2 on the ballot, but regardless of how they vote, Utah lawmakers say they will pass a bill on medical marijuana post election.
At the age of 11, Emma Boniface watched her mother lose herself in the grasp of an opioid addiction.
The Ontario Cannabis Store made a rather sensitive mistake on its online cannabis marketplace on its first day of cannabis sales.
After opening offices in Sydney and Melbourne, Cannabis Access Clinics has opened Queensland’s first cannabis clinic in the Brisbane suburb of Belmont.
In early October, Canopy Growth Corporation announced a six-month study tracking and monitoring the effects of medical cannabis as an alternative to other forms of pain management. Canopy partnered with the Ontario Long Term Care Association for the project.
Israeli-based Together Pharma announced on Tuesday that it will partner with Premier Dead Sea to sell a cosmetic line based on cannabis and Dead Sea minerals. The products, which have not specifically been announced yet, will focus on CBD infusion.
As more states legalize cannabis, a new study has found many patients are choosing medical cannabis to supplement and even replace pharmaceutical drugs.
B.C. Cancer will lead a first-ever national clinical trial to determine whether cannabis plant extracts truly help with symptom relief. The trial will examine how cannabis properties affect and possibly reduce cancer-related symptoms including pain, sleep disturbance, anxiety and nausea.
The Canadian arthritis society has dedicated a page on its website to those considering medical cannabis as a means to treat their pain and inflammation.
Speaking at Digestive Disease Week in Washington, two doctors, one from Toronto’s Mount Sinai hospital, and the other from Meir General hospital in Israel, gave separate presentations on cannabis treatments for inflammatory bowel disease (IBD) and ulcerative colitis (UC).
A write up in medical news today summed up how and why patients are using CBD to help treat their arthritis.
Chronic pain is the most common reason consumers give when enrolling in state-approved medical cannabis programs, according to an analysis of 15 states published by the Journal of Health Affairs on Monday.
In a new profile released by the Globe and Mail, retired NHL enforcer Riley Cote sets to explain how and why he became one of the biggest advocates for medical marijuana in the NHL’s ear.
A new observational study that will have women use a cannabis-based suppository pill aims to determine the effects cannabis can have on menstrual symptoms for women.
Massachusetts-based wellness center Lyme Awareness has added medical cannabis to its list of treatments to help patients with Lyme disease. Although it will not cure the disease, cannabis can be used to aid in symptom management mainly because of its anti-inflammatory properties.
A study out of Montreal that is trying to determine if cannabis can be used as a safer alternative for opiate-based painkillers is having great results thus far.
A new study from a team at the University of New Mexico went through 13,638 user rated cannabis sessions and their effects from 2,830 patients. The results, published in the journal Frontiers in Pharmacology found that patients find relief from a massive amount of symptoms when using medical marijuana.
27 year old free agent Mike James has filed a therapeutic use exemption (TUE) for medical marijuana to the National Football League.
Parkinson’s Foundation Will Gather Experts to Study Cannabis as Disease Therapy
The Beeches Consulting Centre in Manchester, United Kingdom, has welcomed the first specialist medical cannabis clinic. Led by Dr. David McDowell, an independent pain specialist and consultant neurologist Professor Mike Barnes will serve as Clinical Director.
A study conducted by Leiden University Medical Centre (LUMC) and Berocan International in the Netherlands found that standardized high-THC cannabis was effective in treating musculoskeletal pain caused by fibromyalgia.
A new study has found that cannabis oil “significantly” improves Crohn’s disease symptoms.
Senior neurology researcher Dr. Laszlo Mechtler said a 1:1 THC-to-CBD ratio was the most effective at treating symptoms of chronic illness and diminishing undesirable effects for seniors involved in the study.
A study out of McMaster University that performed a systematic review of 17 randomized clinical trials involving 3,161 patients found that though medical cannabis is safe to use, its role in the treatment of multiple sclerosis (MS) symptoms is not well-defined.
A research initiative between Sundial Growers and the University of Saskatchewan will aim to determine whether cannabis could help improve quality of life for people with dementia.
The recently developed Cannabis Research Initiative at the University of California, Los Angeles (UCLA) is determined to test marijuana’s effectiveness to treating pain. Led by Dr. Jeffrey Chen, they intend to gather in-depth research on cannabis, its effects on pain, and its potential as an alternative to opioids.
The University of British Columbia is moving forward on its goal of filling the cannabis research gap, and has created a new professorship to study the possibility of using medical marijuana in treating opioid addictions.
The United States Federal Government is seeking out researchers to investigate how marijuana’s cannabinoids and terpenes work and whether they can treat pain.
In the past few decades, medical institutions have begun to use cannabis as a form of treatment because of its multifarious therapeutic effects. Researchers have conducted years of studies in order to better understand the plant and its effects. Positive results have allowed the integration of cannabis into medical facilities and also helped propel global legalization efforts.
As medical marijuana continues to attract daily headlines, a certain by product of the plant is beginning to get its well-deserved attention. Cannabidiol (pronounced canna-bid-eye-ol) better known as “CBD” is the compound found in the cannabis plant that is showing the most signs for medical treatment. A cousin of the compound Tetrahydrocannabinol (or THC), the compound found in marijuana that gives users the “high” feeling, CBD provides the benefits to patients without the buzz.